PeptiStar to Jointly Exhibit with the Sumitomo Chemical Group at TIDES Europe 2026

2026/10/16

PeptiStar Inc. is pleased to announce that it will jointly exhibit with the Sumitomo Chemical Group at TIDES Europe 2026, an international conference and exhibition focused on oligonucleotide and peptide therapeutics. The event will be held in Amsterdam, the Netherlands, from November 3 to 5, 2026.

At the exhibition, PeptiStar will showcase its contract development and manufacturing organization (CDMO) services for peptide therapeutics, oligonucleotides, siRNA, and gRNA, as well as its scale-up capabilities, GMP manufacturing infrastructure, and ongoing initiatives in the development of new technologies.
Through this joint exhibition with the Sumitomo Chemical Group, PeptiStar aims to present solutions that combine the strengths of both companies to the global market and create new opportunities for collaboration with customers in Japan and overseas who are advancing pharmaceutical development.
During the event, PeptiStar welcomes discussions regarding the research, development, and manufacturing of peptide therapeutics, oligonucleotides, siRNA, and gRNA. Please visit our booth to learn more about our capabilities.
We look forward to welcoming you in Amsterdam.